The fact that analysis of this receptor in our samples was performed using a very sensitive technique (i.e. real-time PCR) and data were confirmed by Western blotting and immunohistochemistry suggests however that CD163 is over-expressed in the inflamed mucosa of IBD patients. This evidence concerns the gene CD163 and inflammatory bowel disease.